Literature DB >> 3440673

Tool for validation of the network of sentinel general practitioners in the Belgian health care system.

M P Lobet1, A Stroobant, R Mertens, V Van Casteren, D Walckiers, G Masuy-Stroobant, R Cornelis.   

Abstract

Morbidity registration by a network of sentinel general practitioners (SGPs) in Belgium raises a number of problems related to possible biases in the network procedure, such as unequal geographical distribution, non-participation of a segment of the target population of practitioners and difficulties in the estimation of the denominator population at risk for the health problems under study. Through the application of two hierarchical clustering procedures, the initial number of 43 districts in the country has been reduced to 15 homogeneous district clusters. These represent the new geographical framework from which the geographical spread of the network is checked. This network is subsequently corrected for such socio-demographic parameters as age, sex and occupation in order to match more closely the total population of Belgian general practitioners (GPs). The population covered by the network is estimated on the basis of the annual number of patient contacts. Application of the described procedures should result in a network allowing valid estimations for a number of health issues as seen by Belgian GPs.

Entities:  

Mesh:

Year:  1987        PMID: 3440673     DOI: 10.1093/ije/16.4.612

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  22 in total

1.  Rectal bleeding and colorectal cancer in general practice: diagnostic study.

Authors:  H Wauters; V Van Casteren; F Buntinx
Journal:  BMJ       Date:  2000-10-21

2.  The incidence of stroke and transient ischaemic attacks is falling: a report from the Belgian sentinel stations.

Authors:  Frank Buntinx; Dirk Devroey; Viviane Van Casteren
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

3.  Euthanasia in patients dying at home in Belgium: interview study on adherence to legal safeguards.

Authors:  Tinne Smets; Johan Bilsen; Lieve Van den Block; Joachim Cohen; Viviane Van Casteren; Luc Deliens
Journal:  Br J Gen Pract       Date:  2010-04       Impact factor: 5.386

4.  Influenza surveillance.

Authors:  Y Ghendon
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

5.  A new influenza surveillance system in France: the Ile-de-France "GROG". 1. Principles and methodology.

Authors:  C Hannoun; W Dab; J M Cohen
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

6.  Incidence and management of presumption of Lyme borreliosis in Belgium: recent data from the sentinel network of general practitioners.

Authors:  K Vanthomme; N Bossuyt; N Boffin; V Van Casteren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-06       Impact factor: 3.267

7.  Physician reports of medication use with explicit intention of hastening the end of life in the absence of explicit patient request in general practice in Belgium.

Authors:  Koen Meeussen; Lieve Van den Block; Nathalie Bossuyt; Michael Echteld; Johan Bilsen; Luc Deliens
Journal:  BMC Public Health       Date:  2010-04-09       Impact factor: 3.295

8.  Diagnosis and treatment of type 2 diabetes in three Belgian regions. Registration via a network of sentinel general practices.

Authors:  J Wens; V Van Casteren; E Vermeire; P Van Royen; L Pas; J Denekens
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

9.  GPs' awareness of patients' preference for place of death.

Authors:  Koen Meeussen; Lieve Van den Block; Nathalie Bossuyt; Johan Bilsen; Michael Echteld; Viviane Van Casteren; Luc Deliens
Journal:  Br J Gen Pract       Date:  2009-09       Impact factor: 5.386

10.  Euthanasia and other end of life decisions and care provided in final three months of life: nationwide retrospective study in Belgium.

Authors:  Lieve Van den Block; Reginald Deschepper; Johan Bilsen; Nathalie Bossuyt; Viviane Van Casteren; Luc Deliens
Journal:  BMJ       Date:  2009-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.